<?xml version="1.0" encoding="utf-8"?>
<?xml-stylesheet type="text/xsl" href="http://medicalxpress.com/tmpl/default/css/default/feedRSS.xsl"?>
<rss version="2.0" 
	xmlns:media="http://search.yahoo.com/mrss/">
<channel>
<title>Medical Xpress: PHYSorg news tagged with: kinase</title>
<link>http://medicalxpress.com/</link>
<language>en-us</language> 
<description>Medical Xpress internet news portal provides the latest news on Health and Medicine.</description>

 <item>
     <title>Novel experimental agent is highly active in CLL patients, interim study shows</title>
   	 <description>An interim analysis of a phase II clinical trial indicates that a novel experimental agent for chronic lymphocytic leukemia (CLL) is highly active and well tolerated both in patients who are undergoing treatment for the first time and those who have relapsed and are resistant to other therapy.</description>
     <link>http://medicalxpress.com/news/2011-06-experimental-agent-highly-cll-patients.html</link>
	 <category>Cancer</category>
	 <pubDate>Mon, 06 Jun 2011 09:42:26 EST</pubDate>
	 <guid isPermaLink="false">news226572134</guid>
	 
</item>
<item>
     <title>The protein that makes us remember pain</title>
   	 <description>(PhysOrg.com) -- New research by scientists in Arizona in the US has demonstrated that an enzyme makes the body remember and remain sensitive to pain after an injury has healed.</description>
     <link>http://medicalxpress.com/news/2011-05-protein-pain.html</link>
	 <category>Neuroscience</category>
	 <pubDate>Fri, 13 May 2011 06:40:01 EST</pubDate>
	 <guid isPermaLink="false">news224480455</guid>
	 
</item>


</channel>
</rss>
